Related Experiment Video
Updated: Aug 15, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Beyond guidelines: achieving the optimum in LDL cholesterol control
Eyal Leibovitz1, Rafi Bitzur, Dror Harats
1Department of Medicine, Wolfson Medical Center, Holon, Israel. leibovitz@wolfson.health.gov.il
Insights
Many patients, especially those at high risk, do not meet LDL cholesterol targets due to undertreatment. Improving hyperlipidemia management requires addressing patient compliance, drug efficacy, cost, and physician care quality.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Pharmacoeconomics
Background:
- Despite established guidelines, a significant portion of the population fails to achieve target low-density lipoprotein (LDL) cholesterol levels.
- This issue is particularly pronounced in high-risk patient groups, with many remaining untreated or undertreated.
Purpose of the Study:
- To review the key challenges in managing hyperlipidemia across large populations.
- To identify critical factors influencing the effectiveness of cholesterol-lowering treatments.
Main Methods:
- Literature review focusing on patient compliance, drug efficacy, cost-benefit analyses, and physician quality of care in hyperlipidemia management.
- Synthesis of current evidence and treatment strategies.
Main Results:
- Patient compliance significantly impacts treatment success.
- Drug efficacy, cost-effectiveness, and physician quality of care are crucial determinants of achieving LDL cholesterol targets.
- A multifaceted approach is necessary for effective hyperlipidemia control.
Conclusions:
- Comprehensive programs are essential to improve hyperlipidemia control.
- Empowering primary care physicians with appropriate tools is vital for optimizing patient treatment and achieving therapeutic goals.
Purpose Of Review:
Despite clear treatment guidelines, a major part of the population is not achieving the recommended LDL cholesterol target levels. This fact is more prominent among high-risk populations in which the majority of patients are untreated or undertreated.
Recent Findings:
The review will elaborate on the key issues of treating large populations: patient compliance, drug efficacy, cost-benefit, and physician quality of care.
Summary:
A programme aimed at improving control of hyperlipidemia should address all four issues. The primary care physician should be empowered and given tools for optimizing treatment.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...